Skip to Content

PAD 133 (Hydrochlorothiazide and Moexipril Hydrochloride 12.5 mg / 7.5 mg)

Pill with imprint PAD 133 is Yellow, Elliptical / Oval and has been identified as Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg. It is supplied by Paddock Laboratories, Inc..

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 12.5 mg / 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for PAD 133

Hydrochlorothiazide and moexipril hydrochloride

PAD 133
12.5 mg / 7.5 mg
Elliptical / Oval
Prescription only
Drug Class:
ACE inhibitors with thiazides
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Paddock Laboratories, Inc.
Inactive Ingredients:
magnesium oxide
magnesium stearate
silicon dioxide
titanium dioxide
polyethylene glycol 400
ferric oxide red
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.